Next, we investigated if CD157 signaling could protect AML blasts from apoptosis induced by therapeutic drugs, such as AraC, a mainstay of AML treatment, thus potentially interfering with the efficacy of chemotherapy. The gene discussed is BST1; the disease is acute myeloid leukemia.